AJP - Heart AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (September 2, 2004). doi:10.1152/ajpheart.00615.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/H416    most recent
00615.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Popovic, Z. B
Right arrow Articles by Thomas, J. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Popovic, Z. B
Right arrow Articles by Thomas, J. D
Submitted on June 21, 2004
Accepted on August 27, 2004

Effects of Sodium Nitroprusside in Aortic Stenosis Associated with Severe Heart Failure: Pressure-Volume Loop Analysis Using A Numerical Model

Zoran B Popovic1, Umesh N Khot2, Gian M Novaro1, Fernando Casas1, Neil L Greenberg1, Mario J Garcia1, Gary S Francis1, and James D Thomas1*

1 Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA
2 Indiana Heart Physicians, Indianapolis, Indiana, USA

* To whom correspondence should be addressed. E-mail: thomasj{at}ccf.org.

In the recently published clinical study (UNLOAD), sodium nitroprusside (NTP) improved cardiac function in patients with severe aortic stenosis (AS) and left ventricular (LV) systolic dysfunction. We explored possible mechanisms of these findings using a series of numerical simulations. A closed-loop lumped parameters model that consists of 24 differential equations relating pressure and flow throughout the circulation was used to analyze the effects of varying hemodynamic conditions in AS. Hemodynamic data from UNLOAD study subjects were used to construct the initial simulation. Systemic vascular resistance, heart rate and aortic valve area were directly entered into the model while end-systolic and diastolic pressure-volume (PV) relationships were adjusted using previously published data to match modeled and observed end-systolic and end-diastolic pressures and volumes. Initial simulation of NTP treatment by reduction of SVR was not adequate. In order to obtain realistic model hemodynamics that reliably reproduce NTP treatment effects, we performed a series of simulations while simultaneously changing end-systolic elastance (Ees), end-systolic volume at zero pressure (V0), and diastolic pressure volume shift. Our data indicate that either Ees increase or V0 decrease is necessary to obtain realistic model hemodynamics. In 5 patients, we corroborated our findings by using the model to duplicate individual PV loops obtained before and during NTP treatment. In conclusion, using a numerical model, we identified ventricular function parameters that are responsible of improved hemodynamics during NTP infusion in AS with LV dysfunction.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. W. Yancy
Vasodilator therapy for decompensated heart failure.
J. Am. Coll. Cardiol., July 15, 2008; 52(3): 208 - 210.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.